ZetrOZ Systems will be exhibiting at the 2023 Major League Soccer Medical Symposium on December 15-16. They will showcase their sam® wearable ultrasound technology, which has proven to speed up injury healing and help athletes return to the sport. The sam® treatment is used by thousands of professional athletes, including soccer player Sam Gleadle with the Monterey Bay FC. They consider sam® an essential tool for staying game-ready and for recovery pre- and post-game. You can check out a video about it here.
The Professional Soccer Athletic Trainers Society (PSATS) meeting, which will take place at the Harbor Beach Marriott in Fort Lauderdale, Florida, is an excellent opportunity for health professionals to learn about the identification, prevention, and treatment of injuries common among soccer athletes. PSATS is an organization dedicated to promoting safe participation in sports and the welfare of professional soccer athletes. They will emphasize case presentations, updates on current injury recommendations, and methods for returning to sport in common areas affecting soccer players.
The symposium is an ideal event for ZetrOZ Systems to showcase their FDA-cleared products, sam® 2.0 and sam® X1, to a diverse audience of health and sports professionals. On Friday, December 15, ZetrOZ leaders and employees will have informal meetings with team representatives. On Saturday, December 16, the company will have a booth where employees will demonstrate the technology with hands-on application and training.
According to Dr. George Lewis, founder and CEO of ZetrOZ Systems, “The MLS Medical Symposium Vendor show is the perfect platform for ZetrOZ Systems’ breakthrough sustained acoustic medicine products. Our sam® 2.0 and X1 ultrasound devices are clinically proven to accelerate soft tissue healing and relieve pain without invasive procedures, which is ideal for treating professional athletes.”
The symposium underscores the significance of teamwork in addressing sports-related injuries and illnesses and the importance of holistic care that incorporates technological advancements. More than 40 clinical studies document how ZetrOZ Systems’ sustained acoustic medicine effectively promotes injury healing and reduces the need for surgery or potentially addictive pain medications, making it an essential asset for medical professionals.
“Research shows that sustained acoustic medicine can be a valuable aspect of the spectrum of therapies provided by orthopedic surgeons,” Lewis said. “We are grateful for an opportunity to demonstrate our technology to the physicians who care for athletes, who are vulnerable to the soft tissue injuries that our sam® devices are designed to treat.”
ZetrOZ Systems to showcase its cutting-edge sustained acoustic medicine technology at an upcoming event where industry professionals will convene to exchange knowledge and learn about the latest strategies for treating soccer athletes. The company remains committed to driving the research and development of ultrasound therapy in the field of sports medicine.
